PUBLISHER: The Business Research Company | PRODUCT CODE: 1939227
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939227
Angiogram equipment is utilized to examine blood vessels and visualize internal organs within the human body. The process involves injecting a radio-opaque contrast agent into the patient's bloodstream and capturing images using X-ray-based methods.
The primary products within the angiography equipment category include angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCD), angiography balloons, angiography guidewires, and angiography accessories. Angiography equipment, also known as contrast agents or contrast media, enhances the diagnostic value of imaging examinations. The technologies involved in angiography equipment include X-ray angiography, CT angiography, MR angiography, and other advanced imaging technologies. The procedures associated with angiography equipment encompass coronary angiography, endovascular angiography, onco-angiography, and neuro-angiography. These solutions find application across various end-users, including hospitals and clinics, diagnostic and imaging centers, as well as research institutes.
Tariffs are influencing the angiography equipment market by increasing costs of imported imaging systems, x-ray components, contrast agents, catheters, and electronic subsystems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging equipment, while Asia-Pacific faces cost pressure on system exports. These tariffs are raising capital investment requirements and delaying equipment upgrades. However, they are also encouraging local assembly, regional manufacturing partnerships, and development of cost-optimized angiography solutions.
The angiography equipment market research report is one of a series of new reports from The Business Research Company that provides angiography equipment market statistics, including angiography equipment industry global market size, regional shares, competitors with a angiography equipment market share, detailed angiography equipment market segments, market trends and opportunities, and any further data you may need to thrive in the angiography equipment industry. This angiography equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The angiography equipment market size has grown strongly in recent years. It will grow from $13.83 billion in 2025 to $14.98 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of diagnostic imaging infrastructure, rising adoption of catheter-based interventions, growing availability of angiography systems, improved healthcare access.
The angiography equipment market size is expected to see strong growth in the next few years. It will grow to $20.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing demand for advanced vascular imaging, rising adoption of minimally invasive diagnostic procedures, expansion of neuro and cardiac angiography applications, growing investment in digital healthcare infrastructure, increasing focus on imaging accuracy and efficiency. Major trends in the forecast period include increasing adoption of digital angiography systems, rising use of minimally invasive imaging procedures, growing integration of ai-based image analysis, expansion of hybrid operating rooms, enhanced focus on radiation dose reduction.
The increasing prevalence of cardiovascular illnesses is anticipated to fuel the growth of the angiography equipment market. Angiography systems utilize X-ray imaging to identify blockages or narrowing in the blood vessels supplying the heart. The growing incidence of cardiovascular diseases is partly attributed to the long-term health effects of the COVID-19 pandemic, as the virus has been associated with persistent cardiovascular complications and the worsening of pre-existing heart conditions, resulting in a sustained rise in heart-related disorders. A higher burden of cardiovascular illnesses directly drives greater adoption of advanced imaging systems that enable clear visualization of blood vessels and cardiac anatomy, supporting clinicians in diagnosing arterial obstructions, evaluating cardiac function, and guiding appropriate therapeutic interventions. For example, in September 2023, according to a report published by PCRonline, a France-based cardiovascular education platform, nearly 620 million people worldwide were living with heart and circulatory diseases, with approximately 60 million new cases diagnosed annually, underscoring the substantial global impact of cardiovascular conditions. Therefore, the growing frequency of cardiovascular illnesses is expected to continue supporting the expansion of the angiography equipment market.
Leading companies in the angiography equipment market are prioritizing the integration of artificial intelligence (AI) and machine learning to enhance the accuracy of their equipment for the early detection of cardiovascular diseases. AI algorithms can aid in interpreting images, improving diagnostic accuracy, and streamlining workflow efficiency. For example, in October 2023, Abbott, a US-based healthcare and medical devices firm, introduced the Ultreon 1.0 Software, a notable advancement in angiography technology tailored for Optical Coherence Tomography (OCT) applications in interventional cardiology. By combining artificial intelligence (AI) with cutting-edge imaging, the software enhances decision-making processes during percutaneous coronary interventions (PCI). Ultreon 1.0 employs OCT technology to provide physicians with detailed cross-sectional images of coronary arteries, allowing for a more precise evaluation of plaque and coronary artery disease compared to conventional angiography, which facilitates quicker and more accurate stent placements.
In October 2023, Abbott, a US-based healthcare company, revealed its acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition is intended to enhance Abbott's portfolio in the cardiovascular sector and meet the increasing demand for innovative treatments for cardiovascular diseases worldwide. Cardiovascular Systems, Inc. is a US-based medical device firm that specializes in developing and providing angiography equipment, with a particular emphasis on innovative solutions for treating peripheral artery disease (PAD) and coronary artery disease (CAD).
Major companies operating in the angiography equipment market are GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Corporation, Boston Scientific Corporation, Cordis Corporation, Shimadzu Corporation, Medtronic PLC, Angiodynamics, B. Braun Melsungen, Abbott Laboratories, Terumo Corporation, Toshiba Medical System Corporation, Merit Medical Systems Inc., Hitachi Medical Systems, Carestream Health, Guerbet S.A., Bracco Imaging SpA, Lantheus Medical Imaging Inc., Esaote SpA, Mindray Medical International Limited, Neusoft Medical Systems Co. Ltd., Samsung Medison Co. Ltd., FUJIFILM Medical Systems Inc., Ziehm Imaging GmbH, Allengers Medical Systems Limit
Europe was the largest region in the angiography equipment market share in 2025. The regions covered in the angiography equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the angiography equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The angiogram equipment market consists of sales of angiography equipment solutions, flat-panel digital detectors and image intensifiers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Angiography Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses angiography equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for angiography equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The angiography equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.